These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 18804334)

  • 41. Development of clinical trial protocols involving advanced radiation therapy techniques: the European Organisation for Research and Treatment of Cancer Radiation Oncology Group approach.
    Fairchild A; Bar-Deroma R; Collette L; Haustermans K; Hurkmans C; Lacombe D; Maingon P; Poortmans P; Tomsej M; Weber DC; Gregoire V
    Eur J Cancer; 2012 May; 48(7):1048-54. PubMed ID: 22387181
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Breath-hold technique in conventional APPA or intensity-modulated radiotherapy for Hodgkin's lymphoma: Comparison of ILROG IS-RT and the GHSG IF-RT.
    Kriz J; Spickermann M; Lehrich P; Schmidberger H; Reinartz G; Eich H; Haverkamp U
    Strahlenther Onkol; 2015 Sep; 191(9):717-25. PubMed ID: 25876905
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Radiotherapy of follicular lymphoma: updated role and new rules.
    Yahalom J
    Curr Treat Options Oncol; 2014 Jun; 15(2):262-8. PubMed ID: 24700284
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quality of reporting randomized controlled trials (RCTs) in the nursing literature: application of the consolidated standards of reporting trials (CONSORT).
    Smith BA; Lee HJ; Lee JH; Choi M; Jones DE; Bausell RB; Broome ME
    Nurs Outlook; 2008; 56(1):31-37. PubMed ID: 18237622
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [A quality control program for radiotherapy in Hodgkin's disease].
    Hennequin C; Carrié C; Hofstetter S; Cosset JM
    Cancer Radiother; 1999; 3(2):187-90. PubMed ID: 10230379
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quality assurance needs for modern image-based radiotherapy: recommendations from 2007 interorganizational symposium on "quality assurance of radiation therapy: challenges of advanced technology".
    Williamson JF; Dunscombe PB; Sharpe MB; Thomadsen BR; Purdy JA; Deye JA
    Int J Radiat Oncol Biol Phys; 2008; 71(1 Suppl):S2-12. PubMed ID: 18406928
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predictors of radiation pneumonitis in patients receiving intensity modulated radiation therapy for Hodgkin and non-Hodgkin lymphoma.
    Pinnix CC; Smith GL; Milgrom S; Osborne EM; Reddy JP; Akhtari M; Reed V; Arzu I; Allen PK; Wogan CF; Fanale MA; Oki Y; Turturro F; Romaguera J; Fayad L; Fowler N; Westin J; Nastoupil L; Hagemeister FB; Rodriguez MA; Ahmed S; Nieto Y; Dabaja B
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):175-82. PubMed ID: 25863764
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evolution of the techniques of radiation therapy in the management of lymphoma.
    Hoppe RT
    Int J Clin Oncol; 2013 Jun; 18(3):359-63. PubMed ID: 23575469
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quality of reporting of modern randomized controlled trials in medical oncology: a systematic review.
    Péron J; Pond GR; Gan HK; Chen EX; Almufti R; Maillet D; You B
    J Natl Cancer Inst; 2012 Jul; 104(13):982-9. PubMed ID: 22761273
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reduction of the treated volume to involved node radiation therapy as part of combined modality treatment for early stage aggressive non-Hodgkin's lymphoma.
    Verhappen MH; Poortmans PM; Raaijmakers E; Raemaekers JM
    Radiother Oncol; 2013 Oct; 109(1):133-9. PubMed ID: 24021344
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Radiotherapy of Hodgkin's disease: indications, methodology and clinical observations].
    Vitale V; Ricci G; Scielzo G
    Radiol Med; 1976 May; 62(5):342-68. PubMed ID: 1078287
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bad reporting does not mean bad methods for randomised trials: observational study of randomised controlled trials performed by the Radiation Therapy Oncology Group.
    Soares HP; Daniels S; Kumar A; Clarke M; Scott C; Swann S; Djulbegovic B;
    BMJ; 2004 Jan; 328(7430):22-4. PubMed ID: 14703540
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Radiotherapy for localized relapse in patients with non-Hodgkin's lymphoma: a preliminary report.
    Nakamura K; Kunitake N; Kimura M; Shioyama Y; Terashima H; Masuda K
    Radiat Med; 2000; 18(4):245-8. PubMed ID: 11247000
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The radiotherapy quality assurance gap among phase III cancer clinical trials.
    Corrigan KL; Kry S; Howell RM; Kouzy R; Jaoude JA; Patel RR; Jhingran A; Taniguchi C; Koong AC; McAleer MF; Nitsch P; Rödel C; Fokas E; Minsky BD; Das P; Fuller CD; Ludmir EB
    Radiother Oncol; 2022 Jan; 166():51-57. PubMed ID: 34838891
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 18F-FDG PET for posttherapy assessment of Hodgkin's disease and aggressive Non-Hodgkin's lymphoma: a systematic review.
    Terasawa T; Nihashi T; Hotta T; Nagai H
    J Nucl Med; 2008 Jan; 49(1):13-21. PubMed ID: 18077527
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment planning and delivery of involved field radiotherapy in advanced Hodgkin's disease: results from a questionnaire-based audit for the UK Stanford V regimen vs ABVD clinical trial quality assurance programme (ISRCTN 64141244).
    Diez P; Hoskin PJ; Aird EG
    Br J Radiol; 2007 Oct; 80(958):816-21. PubMed ID: 17959922
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Electronic compensation using multileaf collimation for involved field radiation to the neck and mediastinum in non-Hodgkin's lymphoma and Hodgkin's lymphoma.
    MacDonald S; Bernard S; Balogh A; Spencer D; Sawchuk S
    Med Dosim; 2005; 30(2):59-64. PubMed ID: 15922170
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quality of reporting of randomized controlled trials of pharmacologic treatment of bipolar disorders: a systematic review.
    Strech D; Soltmann B; Weikert B; Bauer M; Pfennig A
    J Clin Psychiatry; 2011 Sep; 72(9):1214-21. PubMed ID: 21294992
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Checkpoint inhibitors and radiation treatment in Hodgkin's lymphoma : New study concepts of the German Hodgkin Study Group.
    Baues C; Semrau R; Gaipl US; Bröckelmann PJ; Rosenbrock J; Engert A; Marnitz S
    Strahlenther Onkol; 2017 Feb; 193(2):95-99. PubMed ID: 27704149
    [TBL] [Abstract][Full Text] [Related]  

  • 60. QA makes a clinical trial stronger: evidence-based medicine in radiation therapy.
    Weber DC; Tomsej M; Melidis C; Hurkmans CW
    Radiother Oncol; 2012 Oct; 105(1):4-8. PubMed ID: 22985777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.